nanosynth group plc is a United Kingdom-based company, which is engaged in the development and commercialization of its core nano-particle platform technology. The Company is focused on developing commercial applications to enhance existing products and to develop new products, leveraging its platform nanotechnology and material science across a range of industry sectors and markets. The Company has two operating subsidiaries, Pharm 2 Farm Ltd and Virosynth Ltd, each of which is focused on specific industry applications of the core technology. Pharm2Farm has licenses for two patents relating to nanoparticle production and has filed two additional patents. Pharm2Farm produce and sell these products through a license to this technology from Nottingham Trent University, United Kingdom. Virosynth Limited is engaged in anti-pathogenic product development.